Ivermectin
Ivermectin is a pharmaceutical drug with 98 clinical trials. Currently 9 active trials ongoing. Historical success rate of 88.2%.
Success Metrics
Based on 60 completed trials
Phase Distribution
Phase Distribution
14
Early Stage
27
Mid Stage
44
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
60 of 70 finished
14.3%
10 ended early
9
trials recruiting
98
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy of Ivermectin in the Treatment of Plane Warts
Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations
Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma
Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer
COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
Clinical Trials (98)
Efficacy of Ivermectin in the Treatment of Plane Warts
Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations
Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma
Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer
COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
Rosacea and Ivermectin
Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.
Moxidectin for LF, Cote d'Ivoire (DOLF)
Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases
ACTIV-6: COVID-19 Study of Repurposed Medications
Repeat Ivermectin Mass Drug Administrations for MALaria Control II
Efficacy, Safety, and PK of Ascending Dosages of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis
Effect of Ivermectin Metabolites on Mosquito Survival
Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire
Trial of Combination Therapy to Treat COVID-19 Infection
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 98